Advertisement
U.S. Markets closed

Fresh Tracks Therapeutics, Inc. (FRTX)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
0.71000.0000 (0.00%)
At close: 09:30AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.24M
Enterprise Value -4.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.48
Price/Book (mrq)0.43
Enterprise Value/Revenue -1.14
Enterprise Value/EBITDA 0.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.0300
52 Week Low 30.5500
50-Day Moving Average 30.7656
200-Day Moving Average 30.8871

Share Statistics

Avg Vol (3 month) 33.71k
Avg Vol (10 day) 32.22k
Shares Outstanding 55.97M
Implied Shares Outstanding 6N/A
Float 84.13M
% Held by Insiders 11.55%
% Held by Institutions 129.12%
Shares Short (Nov 30, 2023) 450.18k
Short Ratio (Nov 30, 2023) 40.69
Short % of Float (Nov 30, 2023) 40.85%
Short % of Shares Outstanding (Nov 30, 2023) 40.84%
Shares Short (prior month Oct 31, 2023) 426.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 03, 2019
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -71.12%
Operating Margin (ttm)-79.44%

Management Effectiveness

Return on Assets (ttm)-36.37%
Return on Equity (ttm)-66.50%

Income Statement

Revenue (ttm)8.01M
Revenue Per Share (ttm)1.48
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -6.32M
Net Income Avi to Common (ttm)-5.69M
Diluted EPS (ttm)-1.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.87M
Total Cash Per Share (mrq)1.82
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.98
Book Value Per Share (mrq)1.66

Cash Flow Statement

Operating Cash Flow (ttm)-4.34M
Levered Free Cash Flow (ttm)-2.67M